RegMed XB: het is in 2016 dat Clemens van Blitterswijk samen met Marianne van der Steen, Tom Oostrom en anderen begon aan een ambitieuze reis om een translationeel instituut te creëren dat zich richt op baanbrekende projecten in regeneratieve geneeskunde. Vandaag nemen we afscheid van de eerste directeur van RegMed XB: Marianne van der Steen. In dit artikel blikken we terug op het ontstaan van RegMed XB en kijken we vooruit met Marianne van der Steen.

Representatives of RegMed XB and the RegMed XB Pilot Factory recently traveled to Japan to visit several prime regenerative medicine centers such as CIRA in Kyoto and Osaka University and participate in the EU-Japan Biotech & Pharma Partnering Conference 2023 in Osaka and Bio Japan in Yokohama.

The first edition of the Advanced Therapies Summit, held on October 19th, was a success. Dr. Bart Geers, Chair of the Board at RegMed XB Flanders, welcomed over 170 participants from both Belgium and across the European Union.

The Dutch government has recently conducted interviews with our team to gather insights into the progress of the RegMed XB Pilot Factory. In their latest article, the Rijksoverheid delves into the details of the RegMed XB Pilot Factory, shedding light on how the investments have been utilized and providing an update on its current status.

Smart BioMaterials Consortium (SBMC) and High Tech Campus Eindhoven have joined forces to establish a pilot production facility for smart biomaterials.

We proudly announce the opening of ReGEN Biomedical, the macro tissue pilot line of the RegMed XB Pilot Factory on Thursday, September 21, 2023.